These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7133239)

  • 1. Maturation index values and estradiol blood levels in uterine cervical cancer.
    Schreiner P; Siracký J
    Neoplasma; 1982; 29(4):477-80. PubMed ID: 7133239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic effect in vaginal smears in cancer of the uterine cervix.
    Schreiner P; Siracký J
    Neoplasma; 1978; 25(5):637-9. PubMed ID: 740065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of radiocurability in uterine cervix cancer with a simple cytological test.
    Schreiner P
    Neoplasma; 1981; 28(6):747-52. PubMed ID: 7339503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic activity in lymphocytes from radiation-treated cervical cancer patients.
    Sueblinvong T; Pamutha P
    J Med Assoc Thai; 2003 Feb; 86(2):157-65. PubMed ID: 12678154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of the cervical stump. The radiumhemmet series 1959-1987. Treatment and prognosis.
    Hellström AC; Sigurjonson T; Pettersson F
    Acta Obstet Gynecol Scand; 2001 Feb; 80(2):152-7. PubMed ID: 11167211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between estradiol blood levels and karyopyknotic index (KPI) values in uterine cervical cancer.
    Schreiner P; Siracký J; Kolena J
    Gynecol Oncol; 1980 Aug; 10(1):1-5. PubMed ID: 7399326
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation between serum estradiol/progesterone ratio and survival length in invasive squamous cell cervical cancer.
    Hellberg D; Lindström AK; Stendahl U
    Anticancer Res; 2005; 25(1B):611-6. PubMed ID: 15816635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
    Ma SK; Wu LY; Sun YC; Li B; Zhang HT
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
    Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
    J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
    Al-Farra HM; Al-Fahoum SK; Tabbaa MA
    Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Photodynamic therapy (PDT) for early cervical cancer].
    Muroya T; Suehiro Y; Umayahara K; Akiya T; Iwabuchi H; Sakunaga H; Sakamoto M; Sugishita T; Tenjin Y
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):47-56. PubMed ID: 8546469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cholinesterase activity in patients with uterine cervical cancer during radiotherapy.
    Bradamante V; Smigovec E; Buković D; Geber J; Matanić D
    Coll Antropol; 2000 Dec; 24(2):373-80. PubMed ID: 11216405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
    Onishi H; Yamaguchi M; Kuriyama K; Tsukamoto T; Ishigame K; Ichikawa T; Aoki S; Yoshikawa T; Araki T; Nambu A; Araki T; Hashi A; Yasumizu T; Hoshi K; Ito H
    Cancer J Sci Am; 2000; 6(1):40-5. PubMed ID: 10696738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estradiol receptors in cervical intraepithelial neoplasia and cervico-uterine cancer].
    González-Sánchez JL; Calzada-Sánchez L; Galindo-Vital A; Salazar-Esquivel L
    Ginecol Obstet Mex; 1996 Oct; 64():438-42. PubMed ID: 8974946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
    Torbé B
    Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
    Clement PB; Zubovits JT; Young RH; Scully RE
    Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of RCAS1 as a biomarker of uterine cancer.
    Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
    Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.